Stay updated on Epacadostat Plus Pembrolizumab in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Epacadostat Plus Pembrolizumab in Gastric Cancer Clinical Trial page.

Latest updates to the Epacadostat Plus Pembrolizumab in Gastric Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision: v3.3.2 was added and v3.2.0 was removed, a metadata update that does not alter study content or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedRemoved the banner warning about potential delays in website updates due to a lapse in government funding. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check33 days agoChange DetectedThe page shows only minor formatting/layout tweaks with no updates to essential study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check62 days agoChange DetectedUpdated operating-status notice and version to v3.2.0; removed a specific resource entry (Carcinoma of esophagus).SummaryDifference3%

- Check69 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

- Check84 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed.SummaryDifference0.2%

Stay in the know with updates to Epacadostat Plus Pembrolizumab in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat Plus Pembrolizumab in Gastric Cancer Clinical Trial page.